Director Medical Affairs, Rare Epilepsies Evidence Generation

Director Medical Affairs, Rare Epilepsies Evidence Generation

Join us as the Director of Rare Epilepsies Evidence Generation within US Medical Affairs  a strategic partner and leader across the enterprise, research, development, and commercial functions, you will ensure the alignment of Developmental Epileptic Encephalopathies (DEEs) strategies with the needs of patients, healthcare professionals, payers, and policy makers.

Remote/Commuter Opportunity – Open to candidates within the United States.

SUMMARY – The Director drives medical insight generation, material development, scientific communications, external engagement, and strategic evidence generation to support launch readiness and lifecycle planning.

• Lead brand evidence generation plans, partnering globally on design and execution of Phase IIIb/IV studies, registries, and real‑world evidence, and present plans to leadership.
• Build US Investigator‑Initiated Trial strategy, review proposals, and present to leadership for approval.
• Lead internal and external initiatives to identify evidence gaps, prioritize, and execute in partnership with Clinical, economics and outcomes, and real‑world evidence teams.
• Create opportunities for collaboration with external experts on research to progress knowledge for the field of rare epilepsies.
• Partner compliantly with patient advocacy groups on opportunities for patient‑ and caregiver‑focused research.
• Support Market Access teams on evidence strategy to strengthen product value.
• In partnership with publication lead, build and execute a strategic publication plan for research projects.
• Provide US perspectives to Global teams on evidence strategy and needs.
• Provide medical perspectives to internal stakeholders (Commercial, Market Access, Regulatory, Clinical Development, Pharmacovigilance) to ensure alignment with integrated evidence generation plans.
• Identify, develop, and maintain strong networks with key external stakeholders including investigators, thought leaders and healthcare practitioners.
• Remain aware of evolving disease area trends and competitor activities to anticipate changes and assess impact on US and Global strategy.

• Doctoral degree (PhD, Pharm
  
  D, or MD).
• 5+ years of progressive, non‑field‑based Medical Affairs experience in the pharmaceutical, biotech or medical device industry.
• Minimum 2+ years’ experience contributing to medical strategy development, launch readiness, scientific communications, publication planning, and medical congress management for rare diseases; at least 1 year driving strategy for a rare neurology asset.
• Led implementation of evidence generation initiatives, including study protocols, registries, and publication planning.
• Designed and executed Medical Education programs (CME and non‑CME) aligned with brand and medical objectives.
• Acted as a medical reviewer in the promotional materials review process.
• Collected, analyzed, and translated clinical and scientific insights to inform strategic planning.
• Applied strong scientific acumen, analytical thinking, and problem‑solving to support data‑driven decision‑making.
• Built and sustained collaborative relationships across cross‑functional teams and external experts.
• Led and developed team members, managing multiple priorities in a fast‑paced environment with a strong patient focus.
• Communicated complex scientific and clinical information effectively with clarity and impact.
• Maintained the highest standards of integrity, ethics, confidentiality, and professionalism.

• Proven ability to engage externally as an authentic, long‑term member of the rare disease community.
• Demonstrated experience partnering with patient advocacy groups as informed collaborators.
• Recognized within the rare disease ecosystem for authenticity, transparency, and enduring community commitment.
• Deep understanding of rare disease best practices, including advocacy, access, policy, media relations, and patient support programs.
• Skilled in developing and executing innovative strategies through trusted partnerships with rare disease leaders and alliances.
• Highly proactive,…